Found 0 matching trials
Alpha Radiation Emitters Device (DaRT) for the Treatment of Liver Metastases
NAThis is a single center study enrolling up to 10 patients. The primary obje...
Location
e McGill University Health Centre (MUHC)
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer
NAA unique approach for cancer treatment employing intratumoral diffusing alp...
Status
Active Not Recruiting
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer
NAThis is a multi-center clinical study enrolling up to 12 participants . The...
Location
Multiple Locations
A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT
N/AEvaluation of long-term efficacy outcomes of patients previously treated wi...
Location
Davidof Cancer Institution at the Rabin Medical Center Israel
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)
NAA unique approach for Skin Squamous Cell Carcinoma (SCC) treatment employin...
Location
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.)
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NAA unique approach for cancer treatment employing intratumoral diffusing alp...
Location
RAMBAM Health Care Campus
Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC
NAA unique approach for cancer treatment employing intratumoral diffusing alp...
Location
Sharett institute, Hadassah University Hospital - Ein-Kerem
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NAA unique approach for cancer treatment employing intratumoral diffusing alp...
Location
Sharett institute, Hadassah Medical Center - Ein-Kerem
Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC
NAA unique combinational treatment for cancer employing intratumoral diffusin...
Location
Sharett institute, Hadassah University Hospital - Ein-Kerem
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
NAThis is a multi-center clinical study enrolling up to 28 participants. The ...